Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-24-047979
Filing Date
2024-11-27
Accepted
2024-11-27 16:21:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 ny20036484x5_424b5.htm 424B5 456636
2 logo_gyrex3.jpg GRAPHIC 26588
3 logo_gyrex4.jpg GRAPHIC 27505
4 logo_gyrex5.jpg GRAPHIC 51901
  Complete submission text file 0001140361-24-047979.txt   603340
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283237 | Film No.: 241511501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)